Collegium Pharmaceutical, Inc. Common Stock (COLL) is a publicly traded Healthcare sector company. As of September 8, 2026, COLL trades at $23.30 with a market cap of $766.03M and a P/E ratio of 15.48. COLL moved +0.00% today. Year to date, COLL is -49.18%; over the trailing twelve months it is -38.60%. Its 52-week range spans $23.23 to $50.79. Analyst consensus is strong buy with an average price target of $49.25. Rallies surfaces COLL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for COLL, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $23.30 |
| Market Cap | $766.03M |
| P/E Ratio | 15.48 |
| EPS | $1.52 |
| Dividend Yield | 0.00% |
| 52-Week High | $50.79 |
| 52-Week Low | $23.23 |
| Volume | 499 |
| Avg Volume | 0 |
| Revenue (TTM) | $808.21M |
| Net Income | $47.91M |
| Gross Margin | 60.02% |
4 analysts cover COLL: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $49.25.